BridgeBio Pharma (BBIO) PT Raised to $91 at BTIG
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $80.35 -0.89%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 9 | New: 13
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 9 | New: 13
Join SI Premium – FREE
BTIG analyst Thomas Shrader raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $91.00 (from $49.00) while maintaining a Buy rating.
You May Also Be Interested In
- Calumet Specialty Products Partners (CLMT) PT Raised to $47 at UBS
- Dollar Tree (DLTR) PT Raised to $138 at Truist Securities
- BXP Inc. (BXP) PT Raised to $70 at UBS as Earnings Outlook Accelerates
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
